✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Chandra Bhagat Pharma Ltd.

CBPL

Market Cap
₹45 Cr.
P/E
29.58

Chandra Bhagat Pharma Ltd.

  • Chandra Bhagat Pharm
  • Deccan Health Care
  • Walpar Nutritions
FAQs on Chandra Bhagat Pharma Ltd. Shareprice

Chandra Bhagat Pharm has given lower returns compared to its competitors.
Chandra Bhagat Pharm has grown at ~-47.76% over the last 1yrs while peers have grown at a median rate of -10.01%

Chandra Bhagat Pharm is not expensive.
Latest PE of Chandra Bhagat Pharm is 29.58, while 3 year average PE is 151.
Also latest EV/EBITDA of Chandra Bhagat Pharm is 0 while 3yr average is 19.87.

View FAQ's On Business
Growth Table
  • Chandra Bhagat Pharma Ltd.
  • Deccan Health Care
  • Walpar Nutritions
Balance Sheet
  • Chandra Bhagat Pharma Ltd.
  • Deccan Health Care
  • Walpar Nutritions
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Chandra Bhagat Pharma Ltd.
  • Deccan Health Care
  • Walpar Nutritions
Cash Flow
  • Chandra Bhagat Pharma Ltd.
  • Deccan Health Care
  • Walpar Nutritions
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Chandra Bhagat Pharma Ltd.
  • Deccan Health Care
  • Walpar Nutritions
Quarterly Results
  • Chandra Bhagat Pharma Ltd.
  • Deccan Health Care
  • Walpar Nutritions
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Chandra Bhagat Pharma Ltd. Financials

Balance sheet of Chandra Bhagat Pharm is moderately strong.

Yes, The debt of Chandra Bhagat Pharm is increasing.
Latest debt of Chandra Bhagat Pharm is ₹20.33 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹6.67 Crs.

Yes, profit is increasing.
The profit of Chandra Bhagat Pharm is ₹1.58 Crs for TTM, ₹1.53 Crs for Mar 2024 and ₹0.91 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Chandra Bhagat Pharm latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech